160 related articles for article (PubMed ID: 26942056)
1. Failure recovery of circulating NKG2D
Gao J; Duan Z; Zhang L; Huang X; Long L; Tu J; Liang H; Zhang Y; Shen T; Lu F
Oncoimmunology; 2016; 5(1):e1048061. PubMed ID: 26942056
[TBL] [Abstract][Full Text] [Related]
2. Tumor-Derived Soluble MICA Obstructs the NKG2D Pathway to Restrain NK Cytotoxicity.
Luo Q; Luo W; Zhu Q; Huang H; Peng H; Liu R; Xie M; Li S; Li M; Hu X; Zou Y
Aging Dis; 2020 Feb; 11(1):118-128. PubMed ID: 32010486
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of soluble MICA levels in the serum of patients with advanced hepatocellular carcinoma.
Li JJ; Pan K; Gu MF; Chen MS; Zhao JJ; Wang H; Liang XT; Sun JC; Xia JC
Chin J Cancer; 2013 Mar; 32(3):141-8. PubMed ID: 22704489
[TBL] [Abstract][Full Text] [Related]
4. Impaired circulating CD56
Jiang Y; Chen Y; Chen L; Yao W; Guan J; Liu X; Wei X; Lin X
Hum Immunol; 2020 Jan; 81(1):32-40. PubMed ID: 31735440
[TBL] [Abstract][Full Text] [Related]
5. Impairment of natural killer cell and dendritic cell functions by the soluble form of MHC class I-related chain A in advanced human hepatocellular carcinomas.
Jinushi M; Takehara T; Tatsumi T; Hiramatsu N; Sakamori R; Yamaguchi S; Hayashi N
J Hepatol; 2005 Dec; 43(6):1013-20. PubMed ID: 16168521
[TBL] [Abstract][Full Text] [Related]
6. Increased natural killer cell subsets with inhibitory cytokines and inhibitory surface receptors in patients with recurrent miscarriage and decreased or normal subsets in kidney transplant recipients late post-transplant.
Zhu L; Aly M; Wang H; Karakizlis H; Weimer R; Morath C; Kuon RJ; Toth B; Ekpoom N; Opelz G; Daniel V
Clin Exp Immunol; 2018 Aug; 193(2):241-254. PubMed ID: 29679490
[TBL] [Abstract][Full Text] [Related]
7. Altered Expression of Natural Cytotoxicity Receptors and NKG2D on Peripheral Blood NK Cell Subsets in Breast Cancer Patients.
Nieto-Velázquez NG; Torres-Ramos YD; Muñoz-Sánchez JL; Espinosa-Godoy L; Gómez-Cortés S; Moreno J; Moreno-Eutimio MA
Transl Oncol; 2016 Oct; 9(5):384-391. PubMed ID: 27641642
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxicity of Human Hepatic Intrasinusoidal CD56
Hwang S; Han J; Baek JS; Tak E; Song GW; Lee SG; Jung DH; Park GC; Ahn CS; Kim N
Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30925759
[TBL] [Abstract][Full Text] [Related]
9. Decreased CD122 on CD56
Han W; Ni Q; Liu K; Yao Y; Zhao D; Liu X; Chen Y
Life Sci; 2018 Feb; 195():53-60. PubMed ID: 29307521
[TBL] [Abstract][Full Text] [Related]
10. The imbalance between NKG2A and NKG2D expression is involved in NK cell immunosuppression and tumor progression of patients with hepatitis B virus-related hepatocellular carcinoma.
Yu L; Sun L; Liu X; Wang X; Yan H; Pu Q; Xie Y; Jiang Y; Du J; Yang Z
Hepatol Res; 2023 May; 53(5):417-431. PubMed ID: 36628564
[TBL] [Abstract][Full Text] [Related]
11. An Anti-MICA/B Antibody and IL-15 Rescue Altered NKG2D-Dependent NK Cell Responses in Hepatocellular Carcinoma.
Mantovani S; Varchetta S; Mele D; Donadon M; Torzilli G; Soldani C; Franceschini B; Porta C; Chiellino S; Pedrazzoli P; Santambrogio R; Barabino M; Cigala C; Piccolo G; Opocher E; Maestri M; Sangiovanni A; Bernuzzi S; Lhospice F; Kraiem M; Mondelli MU; Oliviero B
Cancers (Basel); 2020 Nov; 12(12):. PubMed ID: 33266137
[TBL] [Abstract][Full Text] [Related]
12. Natural Killer Group 2A Expressed on Both Peripheral CD3
Yi RT; Niu YH; Liu HL; Zhang TY; Yang YC; Zhang Y; Yin DL; Chen TY; Zhao YR
J Interferon Cytokine Res; 2016 Dec; 36(12):689-697. PubMed ID: 27828717
[TBL] [Abstract][Full Text] [Related]
13. Immunoglobulin-like transcript 2 as an impaired anti-tumor cytotoxicity marker of natural killer cells in patients with hepatocellular carcinoma.
Sakata T; Yoshio S; Yamazoe T; Mori T; Kakazu E; Aoki Y; Aoyanagi N; Okamoto T; Ito T; Toyoda H; Kawaguchi T; Ono Y; Takahashi Y; Taketomi A; Kanto T
Front Immunol; 2024; 15():1389411. PubMed ID: 38638429
[TBL] [Abstract][Full Text] [Related]
14. Distinct natural killer cells in HIV-exposed seronegative subjects with effector cytotoxic CD56(dim) and CD56(bright) cells and memory-like CD57⁺NKG2C⁺CD56(dim) cells.
Lima JF; Oliveira LM; Pereira NZ; Mitsunari GE; Duarte AJ; Sato MN
J Acquir Immune Defic Syndr; 2014 Dec; 67(5):463-71. PubMed ID: 25230289
[TBL] [Abstract][Full Text] [Related]
15. MICA immune complex formed with alpha 3 domain-specific antibody activates human NK cells in a Fc-dependent manner.
Du C; Bevers J; Cook R; Lombana TN; Rajasekaran K; Matsumoto M; Spiess C; Kim JM; Ye Z
J Immunother Cancer; 2019 Aug; 7(1):207. PubMed ID: 31387641
[TBL] [Abstract][Full Text] [Related]
16. Early Cytomegalovirus Reactivation and Expansion of CD56
Jang JE; Hwang DY; Chung H; Kim SJ; Eom JI; Jeung HK; Song J; Kim JS; Cheong JW; Min YH
Biol Blood Marrow Transplant; 2019 Oct; 25(10):2070-2078. PubMed ID: 31212079
[TBL] [Abstract][Full Text] [Related]
17. Recovery of circulating CD56
Liu N; Liu B; Zhang L; Li H; Chen Z; Luo A; Chen M; Peng M; Yin W; Ren H; Hu P
Int Immunopharmacol; 2018 Sep; 62():59-66. PubMed ID: 29990695
[TBL] [Abstract][Full Text] [Related]
18. [Percentages and functions of natural killer cell subsets in peripheral blood of patients with severe aplastic anemia].
Li ZS; Shao ZH; Fu R; Wang J; Li LJ; Zhang T; Wang HQ; Wu YH; Ruan EB; Song J; Qu W; Liu H; Xing LM; Wang XM; Liang Y; Guan J; Wang GJ
Zhonghua Yi Xue Za Zhi; 2011 Apr; 91(16):1084-7. PubMed ID: 21609587
[TBL] [Abstract][Full Text] [Related]
19. [Role of NKG2D-Expressing NK Cells and sMICA in Immune Surveillance of Advanced Lung Cancer.].
Liang J; Han F
Zhongguo Fei Ai Za Zhi; 2009 Jan; 12(1):59-63. PubMed ID: 20712959
[TBL] [Abstract][Full Text] [Related]
20. Terminal Differentiation of CD56(dim)CD16(+) Natural Killer Cells Is Associated with Increase in Natural Killer Cell Frequencies After Antiretroviral Treatment in HIV-1 Infection.
Ahmad F; Tufa DM; Mishra N; Jacobs R; Schmidt RE
AIDS Res Hum Retroviruses; 2015 Dec; 31(12):1206-12. PubMed ID: 26352913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]